Moderna

News

Blow to Moderna as EU nixes mRNA vaccine patent

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious disp

News

Moderna swings to loss as COVID sales slump

Shares in Moderna have been under pressure after the company posted a third-quarter loss of $3.6 billion and a steep fall in COVID-19 vaccine sales, although it still thin

Sales & Marketing

The rise and fall of the pandemic overachievers

Ben Hargreaves examines how Pfizer, BioNTech, and Moderna are preparing for a future without COVID-19 revenue

News

COVID, flu combo jab from Pfizer/BioNTech heads for phase 3

A combination COVID-19 and influenza vaccine being developed by Pfizer and BioNTech has generated immune responses against the viruses in a phase 1/2 trial, setting up a p

News

Moderna eyes 2025 approval for COVID, flu combination jab

Moderna’s combined mRNA-based vaccine for COVID-19 and seasonal influenza has been shown to be at least as effective as jabs given separately in a phase 1/2 trial, setting

News

Moderna looks to its post-COVID growth prospects

With sales of its COVID-19 vaccines on the wane, Moderna has showcased the projects it will look to for the next phase of its development, headed by new vaccines for influ

Blow to Moderna as EU nixes mRNA vaccine patent

Moderna swings to loss as COVID sales slump

The rise and fall of the pandemic overachievers

COVID, flu combo jab from Pfizer/BioNTech heads for phase 3

Moderna eyes 2025 approval for COVID, flu combination jab

Moderna looks to its post-COVID growth prospects

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Moderna

Editor's Picks